Imagion Biosystems Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B was announced 26th April 2019. Download Appendix 4C for the quarter ended 31 March, 2019.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal